The U.S. Drug Enforcement Administration is currently “conducting its review” of an earlier recommendation that the agency reschedule marijuana, a DEA official recently told a federal lawmaker.
The potential rescheduling of marijuana started with President Joe Biden’s October 2022 executive order that federal cabinet-level agencies reexamine the drug’s status under U.S. law.
ADVERTISEMENT
Biden’s edict led to an Aug. 29 recommendation by the Department of Health and Human Services that the DEA should move marijuana from its current status in Schedule 1 to Schedule 3 of the Controlled Substances Act.
Such a move would unlock significant federal tax reform for beleaguered legal cannabis businesses and also likely advance other federal marijuana reform efforts.
But before any of that can happen, the DEA must propose
Read full article on Marijuana Business Daily
